Deep Dive: The Final Frontier of Sepsis Precision Medicine Online-Stop the mayHEME

Video Transcription

Video Summary

The video transcript discusses the role of hemolysis in sepsis and its impact on organ injury and mortality. The speaker highlights the potential for hemolysis to be a target for precision therapies in sepsis. They delve into the mechanisms of hemolysis and its association with poor outcomes in sepsis. The transcript also covers therapeutic strategies, including the use of haptoglobin and hemopexin, as well as antioxidant drugs to mitigate hemolytic injury. The importance of identifying patients with significant hemolysis and susceptibility to hemolytic injury is emphasized as key to personalizing treatment. Studies on the therapeutic potential of haptoglobin and hemopexin in animal models and clinical trials are discussed, along with open questions regarding patient identification and optimal timing of treatment. In conclusion, the transcript underscores the relevance of hemolysis in sepsis and the potential for targeted therapies based on individual patient needs.

Keywords

hemolysis

sepsis

organ injury

precision therapies

haptoglobin

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.